Long Position on MEDP @ $43.60 on 6/14/2018 (Momentum)

Medpace Holdings, Inc. (MEDP) is a clinical contract research organization.

The company provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide.

The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in a range of therapeutic areas.

Its clinical development services include medical affairs, clinical trial management, feasibility and start-up study, clinical monitoring, global regulatory affairs, medical writing, biometrics, pharmacovigilance, core laboratory, and quality assurance. 

Shares have formed a bullish "cup and handle" and are on the cusp of a breakout. The firm reports its quarterly results on July 31. Higher share prices are expected for this stock.

Entry Point: $43.60

Stop Loss: $41.40

52-Weeks Trading Range: $26.56 - $44.45

Target Price: $47.96

Updates

7/27/2018 9:51:11 AM

MEDP closed at $48.66.

Position closed on 7/27/2018 at price of $48.66 with a 11.61% gain in 43 days.

Back to Portfolio